Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Combe

Showing results (251-260 of 282) with videos related to

Pageof 29
Sort By:
Annals of the Rheumatic Diseases|March 19, 2010
Evidence for treating rheumatoid arthritis to target: results of a systematic literature searchMonika Schoels, Rachel Knevel, Daniel Aletaha, et al.
Clinical Rheumatology|April 29, 2024
Adding ultrasound to treat-to-target shows no benefit in achieving clinical remission nor in slowing radiographic progression in rheumatoid arthritis: results from a multicenter prospective cohortAlexandre Sepriano, Sofia Ramiro, Robert Landewé, et al.
Annals of the Rheumatic Diseases|February 5, 2013
EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteriaDésirée van der Heijde, Annette H M van der Helm-van Mil, Daniel Aletaha, et al.
Annals of the Rheumatic Diseases|December 17, 2016
2016 update of the EULAR recommendations for the management of early arthritisBernard Combe, Robert Landewe, Claire I Daien, et al.
Arthritis and Rheumatism|September 2, 2008
Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countriesTuulikki Sokka, Merete Lund Hetland, Heidi Mäkinen, et al.
RMD Open|September 2, 2021
Lymphoma complicating rheumatoid arthritis: results from a French case-control studyJoanna Kedra, Raphaele Seror, Philippe Dieudé, et al.
Annals of the Rheumatic Diseases|December 25, 2012
Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registryJacques-Eric Gottenberg, Gael Cinquetti, Claire Larroche, et al.
Annals of the Rheumatic Diseases|March 11, 2010
Treating rheumatoid arthritis to target: recommendations of an international task forceJosef S Smolen, Daniel Aletaha, Johannes W J Bijlsma, et al.
Rheumatology (Oxford, England)|October 11, 2023
Prevalence of anti-neutrophil cytoplasmic antibody-associated vasculitis in the south of France, using the capture-recapture methodEmma Rubenstein, Pierrick Henneton, Sophie Rivière, et al.
Seminars in Arthritis and Rheumatism|November 14, 2018
Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysisJocelyn Quistrebert, Signe Hässler, Delphine Bachelet, et al.
Pageof 29

Showing results (251-260 of 282) with videos related to

Sort By:
Pageof 29
Annals of the Rheumatic Diseases|March 19, 2010
Evidence for treating rheumatoid arthritis to target: results of a systematic literature searchMonika Schoels, Rachel Knevel, Daniel Aletaha, et al.
Clinical Rheumatology|April 29, 2024
Adding ultrasound to treat-to-target shows no benefit in achieving clinical remission nor in slowing radiographic progression in rheumatoid arthritis: results from a multicenter prospective cohortAlexandre Sepriano, Sofia Ramiro, Robert Landewé, et al.
Annals of the Rheumatic Diseases|February 5, 2013
EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteriaDésirée van der Heijde, Annette H M van der Helm-van Mil, Daniel Aletaha, et al.
Annals of the Rheumatic Diseases|December 17, 2016
2016 update of the EULAR recommendations for the management of early arthritisBernard Combe, Robert Landewe, Claire I Daien, et al.
Arthritis and Rheumatism|September 2, 2008
Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countriesTuulikki Sokka, Merete Lund Hetland, Heidi Mäkinen, et al.
RMD Open|September 2, 2021
Lymphoma complicating rheumatoid arthritis: results from a French case-control studyJoanna Kedra, Raphaele Seror, Philippe Dieudé, et al.
Annals of the Rheumatic Diseases|December 25, 2012
Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registryJacques-Eric Gottenberg, Gael Cinquetti, Claire Larroche, et al.
Annals of the Rheumatic Diseases|March 11, 2010
Treating rheumatoid arthritis to target: recommendations of an international task forceJosef S Smolen, Daniel Aletaha, Johannes W J Bijlsma, et al.
Rheumatology (Oxford, England)|October 11, 2023
Prevalence of anti-neutrophil cytoplasmic antibody-associated vasculitis in the south of France, using the capture-recapture methodEmma Rubenstein, Pierrick Henneton, Sophie Rivière, et al.
Seminars in Arthritis and Rheumatism|November 14, 2018
Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysisJocelyn Quistrebert, Signe Hässler, Delphine Bachelet, et al.
Pageof 29